Zhongzhu Healthcare Holding Co.,Ltd (600568.SS)

CNY 1.46

(-0.68%)

Market Cap (In CNY)

2.81 Billion

Revenue (In CNY)

580.05 Million

Net Income (In CNY)

-343.93 Million

Avg. Volume

4.04 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
1.13-1.8
PE
-
EPS
-
Beta Value
0.332
ISIN
CNE0000017X8
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Ms. Bo Anna Wang
Employee Count
-
Website
https://www.zz600568.com
Ipo Date
2001-05-18
Details
Zhongzhu Healthcare Holding Co.,Ltd constructs and develops real estate properties in China. It also produces ophthalmic drugs; researches and develops natural botanical drugs. In addition, it researches and develops drugs, such as recombinant human endostatin adenovirus injection, which is an anticancer gene therapy; Genistein capsule for the treatment of postmenopausal osteoporosis; and motherwort that is primarily a gynecological drug. Further, the company offers medical instruments, including radiation therapy, hyperthermia, phototherapy, and ultrasound diagnosis, as well as develops imaging breast tumor detection systems. Additionally, it offers medical services. The company was formerly known as Zhongzhu Holding Co., Ltd. and changed its name to Zhongzhu Healthcare Holding Co.,Ltd in June 2016. Zhongzhu Healthcare Holding Co.,Ltd was founded in 1970 and is headquartered in Qianjiang, China.